financetom
Business
financetom
/
Business
/
Viad to Change Name to Pursuit Attractions and Hospitality
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Viad to Change Name to Pursuit Attractions and Hospitality
Dec 19, 2024 7:34 AM

10:03 AM EST, 12/19/2024 (MT Newswires) -- Viad ( VVI ) said Thursday it will change its name to Pursuit Attractions and Hospitality, effective Dec. 31.

The company said it will start trading under its new NYSE ticker PRSU on Jan. 2.

The move follows the previously disclosed sale of Viad's ( VVI ) GES business, which is slated to close on Dec. 31, leaving Pursuit as its remaining business, the company said.

Price: 42.94, Change: +0.49, Percent Change: +1.15

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Sony Picks Up Film Rights to Labubu Toy Brand
Market Chatter: Sony Picks Up Film Rights to Labubu Toy Brand
Nov 14, 2025
04:01 PM EST, 11/14/2025 (MT Newswires) -- Sony Group ( SONY ) unit Sony Pictures has acquired the screen rights to Labubu, the Chinese plush-toy line, and plans to develop it as a feature film, multiple media outlets reported Friday. The project is in early development with no producers attached, and it is still undecided whether the movie will be...
Brazil's Prumo sells stake in joint venture with Anglo American
Brazil's Prumo sells stake in joint venture with Anglo American
Nov 14, 2025
RIO DE JANEIRO (Reuters) -Brazilian logistics firm Prumo said on Friday it agreed to sell its 50% stake in Ferroport, a joint venture with miner Anglo American that operates an iron ore terminal at Rio de Janeiro's Acu Port. * The Ferroport stake is being sold to investment firm3Point2, which had financial support from lender BTG Pactual,Prumo said in a statement....
Biogen Completes Acquisition of Alcyone Therapeutics
Biogen Completes Acquisition of Alcyone Therapeutics
Nov 14, 2025
CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. ( BIIB ) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative CNS therapy delivery solutions, such as the ThecaFlex DRx™ drug delivery system. ThecaFlex DRx™ is an investigational implantable device designed to provide an alternative to repeat lumbar punctures in chronic intrathecal administration...
Sarepta Gains FDA Approval for Updated Safety Guidance on Duchenne Gene Therapy
Sarepta Gains FDA Approval for Updated Safety Guidance on Duchenne Gene Therapy
Nov 14, 2025
04:00 PM EST, 11/14/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) said Friday that the U.S. Food and Drug Administration has approved updated prescribing information for Elevidys, its gene therapy for Duchenne muscular dystrophy. The update adds a boxed warning for acute liver injury and liver failure, expands prescriber guidance with new monitoring requirements, and removes the therapy's non-ambulatory...
Copyright 2023-2026 - www.financetom.com All Rights Reserved